- Home
- SYNA vs XENE Comparison
SYNA vs XENE Comparison
Compare SYNA & XENE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYNA
- XENE
- Stock Information
- Founded
- SYNA 1986
- XENE 1996
- Country
- SYNA United States
- XENE Canada
- Employees
- SYNA N/A
- XENE N/A
- Industry
- SYNA Computer peripheral equipment
- XENE Biotechnology: Pharmaceutical Preparations
- Sector
- SYNA Technology
- XENE Health Care
- Exchange
- SYNA Nasdaq
- XENE Nasdaq
- Market Cap
- SYNA 2.7B
- XENE 2.9B
- IPO Year
- SYNA 2002
- XENE 2014
- Fundamental
- Price
- SYNA $68.02
- XENE $39.51
- Analyst Decision
- SYNA Strong Buy
- XENE Strong Buy
- Analyst Count
- SYNA 7
- XENE 11
- Target Price
- SYNA $92.17
- XENE $52.73
- AVG Volume (30 Days)
- SYNA 388.2K
- XENE 739.7K
- Earning Date
- SYNA 11-06-2025
- XENE 11-11-2025
- Dividend Yield
- SYNA N/A
- XENE N/A
- EPS Growth
- SYNA N/A
- XENE N/A
- EPS
- SYNA N/A
- XENE N/A
- Revenue
- SYNA $1,074,300,000.00
- XENE $7,500,000.00
- Revenue This Year
- SYNA $11.05
- XENE N/A
- Revenue Next Year
- SYNA $9.89
- XENE $207.88
- P/E Ratio
- SYNA N/A
- XENE N/A
- Revenue Growth
- SYNA 11.98
- XENE N/A
- 52 Week Low
- SYNA $41.80
- XENE $26.74
- 52 Week High
- SYNA $89.81
- XENE $46.00
- Technical
- Relative Strength Index (RSI)
- SYNA 38.69
- XENE 56.70
- Support Level
- SYNA $66.44
- XENE $38.49
- Resistance Level
- SYNA $70.40
- XENE $40.17
- Average True Range (ATR)
- SYNA 1.90
- XENE 1.28
- MACD
- SYNA -0.61
- XENE 0.02
- Stochastic Oscillator
- SYNA 7.22
- XENE 67.55
About SYNA Synaptics Incorporated $0.001 Par Value
Synaptics Inc is a producer of semiconductor solutions for the mobile, PC, and Internet of Things markets. The company develops human interface solutions that enable touch, display, fingerprint, video, audio, voice, AI, and connectivity functions for smartphones, PCs, Internet of Things products, and other electronic devices. It operates in one segment: the development, marketing, and sale of semiconductor products used in electronic devices and products. The company geographically, it derives a majority of revenue from China, and also has its presence in Taiwan, Japan, South Korea, United States and Other countries.
About XENE Xenon Pharmaceuticals Inc.
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.